97 related articles for article (PubMed ID: 20658611)
1. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.
Gorman MF; Ji L; Ko RH; Barnette P; Bostrom B; Hutchinson R; Raetz E; Seibel NL; Twist CJ; Eckroth E; Sposto R; Gaynon PS; Loh ML
Pediatr Blood Cancer; 2010 Sep; 55(3):421-9. PubMed ID: 20658611
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of immature leukemias in children.
Sajiki D; Yoshida N; Muramatsu H; Sakaguchi K; Maeda N; Yokoyama N; Miyajima Y; Tanaka M; Takahashi Y; Hama A
Int J Hematol; 2024 Apr; ():. PubMed ID: 38687412
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and genetic dynamics of acute myeloid leukemia at first relapse.
Bataller A; Kantarjian H; Bazinet A; Kadia T; Daver N; DiNardo CD; Borthakur G; Loghavi S; Patel K; Tang G; Sasaki K; Short NJ; Yilmaz M; Issa GC; Alvarado Y; Montalban-Bravo G; Maiti A; Abbas HA; Takahashi K; Pierce S; Jabbour E; Garcia-Manero G; Ravandi F
Haematologica; 2024 May; ():. PubMed ID: 38695144
[TBL] [Abstract][Full Text] [Related]
4. A critical evaluation of the EFS endpoint in AML: Does induction treatment failure timing have a profound impact on study design and results?
Sidi Y; Dong C; Wu Y; Faller DV
Leuk Res; 2024 Mar; 138():107465. PubMed ID: 38422881
[TBL] [Abstract][Full Text] [Related]
5. Opportunities for immunotherapy in childhood acute myeloid leukemia.
Lamble AJ; Tasian SK
Blood Adv; 2019 Nov; 3(22):3750-3758. PubMed ID: 31770440
[TBL] [Abstract][Full Text] [Related]
6. The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Ceolin V; Ishimaru S; Karol SE; Bautista F; Goemans BF; Gueguen G; Willemse M; Di Laurenzio L; Lukin J; van Tinteren H; Locatelli F; Petit A; Tomizawa D; Norton A; Kaspers G; Reinhardt D; Tasian SK; Nichols G; Kolb EA; Zwaan CM; Cooper TM
Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201506
[TBL] [Abstract][Full Text] [Related]
7. Modeling low-dose radiation-induced acute myeloid leukemia in male CBA/H mice.
Stouten S; Verduyn Lunel S; Finnon R; Badie C; Dekkers F
Radiat Environ Biophys; 2021 Mar; 60(1):49-60. PubMed ID: 33221961
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic.
Al-Hussaini M; DiPersio JF
Expert Rev Hematol; 2014 Aug; 7(4):439-64. PubMed ID: 25025370
[TBL] [Abstract][Full Text] [Related]
9. A Review of Acute Lymphocytic Leukemia (ALL) in the Pediatric Population: Evaluating Current Trends and Changes in Guidelines in the Past Decade.
Ekpa QL; Akahara PC; Anderson AM; Adekoya OO; Ajayi OO; Alabi PO; Okobi OE; Jaiyeola O; Ekanem MS
Cureus; 2023 Dec; 15(12):e49930. PubMed ID: 38179374
[TBL] [Abstract][Full Text] [Related]
10. Relapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.
Davila J; Slotkin E; Renaud T
Paediatr Drugs; 2014 Apr; 16(2):151-68. PubMed ID: 24158739
[TBL] [Abstract][Full Text] [Related]
11. Outcome of refractory and relapsed acute myeloid leukemia in children treated during 2005-2011 - experience of the Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG).
Skalska-Sadowska J; Wachowiak J; ; Skalska-Sadowska J; Wachowiak J; Zając-Spychała O; Niewiadomska-Wojnałowicz I; Januszkiewicz-Lewandowska D; Balwierz W; Pawińska-Wąsikowska K; Goździk J; Chybicka A; Potocka K; Krawczuk-Rybak M; Muszyńska-Rosłan K; Adamkiewicz-Drożyńska E; Maciejka-Kapuścińska L; Karolczyk G; Kowalczyk J; Wójcik B; Badowska W; Urasiński T; Ociepa T; Matysiak M; Sikorska-Fic B; Szczepański T; Tomaszewska R; Sobol G; Wieczorek M; Karpińska-Derda I
Contemp Oncol (Pozn); 2014; 18(1):48-53. PubMed ID: 24876821
[TBL] [Abstract][Full Text] [Related]
12. Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium.
Verma A; Chi YY; Malvar J; Lamble A; Chaudhury S; Agarwal A; Li HT; Liang G; Leong R; Brown PA; Kaplan J; Schafer ES; Slone T; Pauly M; Chang BH; Stieglitz E; Wayne AS; Hijiya N; Bhojwani D
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339248
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcome and prognostic factors in relapsed pediatric acute myeloid leukemia.
Lee JH; Ju HY; Hyun JK; Kim SJ; Cho HW; Lee JK; Lee JW; Sung KW; Yoo KH
Blood Res; 2023 Dec; 58(4):181-186. PubMed ID: 37926557
[TBL] [Abstract][Full Text] [Related]
14. Homoharringtonine-Based Induction Therapy Reduces the Recurrence Rate of Pediatric Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Wang B; Wen X; Zhang R; Zhu G; Wu Y; Zhang Y; Lin W; Yu J; Fan J; Li J; Yang J; Qin M; Zheng H
Cell Transplant; 2023; 32():9636897231183559. PubMed ID: 37470325
[TBL] [Abstract][Full Text] [Related]
15. Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience.
Trabal A; Gibson A; He J; McCall D; Roth M; Nuñez C; Garcia M; Buzbee M; Toepfer L; Bidikian A; Daver N; Kadia T; Short NJ; Issa GC; Ravandi F; DiNardo CD; Montalban Bravo G; Garces S; Marcogliese A; Paek H; Dreyer Z; Brackett J; Redell M; Yi J; Garcia-Manero G; Konopleva M; Stevens A; Cuglievan B
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046645
[TBL] [Abstract][Full Text] [Related]
16. Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023.
Egan G; Tasian SK
Haematologica; 2023 Sep; 108(9):2275-2288. PubMed ID: 36861399
[TBL] [Abstract][Full Text] [Related]
17. T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy.
Horgan C; Mullanfiroze K; Rauthan A; Patrick K; Butt NA; Mirci-Danicar O; O'Connor O; Furness C; Deshpande A; Lawson S; Broderick V; Evans P; Gibson B; Roberts W; Ali S; Galani S; Kirkwood AA; Jovanovic J; Dillon R; Virgo P; James B; Rao K; Amrolia PJ; Wynn RF
Blood Adv; 2023 May; 7(10):2155-2165. PubMed ID: 36649566
[TBL] [Abstract][Full Text] [Related]
18. Relapsed Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Center in Thailand.
Songthawee N; Sripornsawan P; Chavananon S; McNeil EB; Chotsampancharoen T
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4079-4084. PubMed ID: 36579988
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
